AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19214045 — intervention group
Group type: COMPARATOR
Intervention: No-program control
Number of subjects: 86
Study 17255304 — intervention group
Group type: EXPERIMENTAL
Intervention: Sorafenib (400 mg twice daily)
Number of subjects: 0
Study 17255304 — intervention group
Group type: COMPARATOR
Intervention: Sorafenib (compared to placebo)
Number of subjects: 0
Study 17255304 — intervention group
Group type: EXPERIMENTAL
Intervention: Sorafenib (in combination with IFN, bevacizumab, or temsirolimus)
Number of subjects: 0
Study 15124757 — intervention group
Group type: EXPERIMENTAL
Intervention: IFNbeta‐1a 30 mcg IM once weekly
Number of subjects: 608
Study 15124757 — intervention group
Group type: COMPARATOR
Intervention: IFNbeta‐1a 60 mcg IM once weekly
Number of subjects: 608
Study 15124757 — intervention group
Group type: EXPERIMENTAL
Intervention: Both doses of IFNbeta‐1a
Number of subjects: 608
Study 11697022 — intervention group
Group type: EXPERIMENTAL
Intervention: Allicin-containing garlic supplement, one capsule daily for 12 weeks
Number of subjects: 146
Study 11697022 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 146
Study 9561285 — intervention group
Group type: EXPERIMENTAL
Intervention: Performance 1 (P1; 55 mEq Na+, 365 mOsm.kg H2O-1)
Number of subjects: 6
Study 9561285 — intervention group
Group type: EXPERIMENTAL
Intervention: AstroAde (AA; 164 mEq Na+, 253 mOsm.kg-1)
Number of subjects: 6
Study 9561285 — intervention group
Group type: EXPERIMENTAL
Intervention: AA/P1
Number of subjects: 6
Study 9561285 — intervention group
Group type: EXPERIMENTAL
Intervention: P1/P1, P2/P1, P2G/P1
Number of subjects: 6
Study 9561285 — intervention group
Group type: EXPERIMENTAL
Intervention: 0/P1
Number of subjects: 6
Study 9561285 — intervention group
Group type: COMPARATOR
Intervention: 0/0
Number of subjects: 6
Study 7898227 — intervention group
Group type: EXPERIMENTAL
Intervention: LDL apheresis plus simvastatin 40 mg daily
Number of subjects: 39
Study 7898227 — intervention group
Group type: COMPARATOR
Intervention: Colestipol 20 g plus simvastatin 40 mg daily
Number of subjects: 39
Study 2803775 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical fusidic acid 1%
Number of subjects: 80
Study 2803775 — intervention group
Group type: COMPARATOR
Intervention: Topical chloramphenicol 0.5%
Number of subjects: 80
Study 2803775 — intervention group
Group type: COMPARATOR
Intervention: Subconjunctival cephazolin
Number of subjects: 80
Study 1100301 — intervention group
Group type: EXPERIMENTAL
Intervention: Penfluridol (30, 60, and 120 mg weekly)
Number of subjects: 22
Study 1100301 — intervention group
Group type: EXPERIMENTAL
Intervention: Penfluridol
Number of subjects: 22
Study 31389909 — intervention group
Group type: COMPARATOR
Intervention: Statins (10 mg of rosuvastatin)
Number of subjects: 83
Study 31389909 — intervention group
Group type: COMPARATOR
Intervention: Placebo + Exercise Training (PLET)
Number of subjects: 83
Study 31389909 — intervention group
Group type: COMPARATOR
Intervention: Statins + Exercise Training (STAET)
Number of subjects: 83
Study 28255102 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple-Antiplatelet Therapy (TAPT) with cilostazol
Number of subjects: 133
Study 28255102 — intervention group
Group type: COMPARATOR
Intervention: Dual-Antiplatelet Therapy (DAPT) (aspirin and clopidogrel)
Number of subjects: 133
Study 26638888 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 44
Study 26638888 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 44
Study 26638888 — intervention group
Group type: COMPARATOR
Intervention: Both interventions
Number of subjects: 44
Study 23414490 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher IL-6 concentration
Number of subjects: 5653
Study 23414490 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-6 -174 CC genotype
Number of subjects: 5653
Study 21150649 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-day weighed food records
Number of subjects: 1368
Study 21150649 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized training for dietitians
Number of subjects: 1368
Study 20074436 — intervention group
Group type: EXPERIMENTAL
Intervention: Phytothermotherapy at the thermal resort of Garniga Terme (Trento, Italy)
Number of subjects: 56
Study 20074436 — intervention group
Group type: COMPARATOR
Intervention: Control group (26 patients)
Number of subjects: 56
Study 17071020 — intervention group
Group type: EXPERIMENTAL
Intervention: Bi-weekly judicial status hearings
Number of subjects: 0
Study 17071020 — intervention group
Group type: COMPARATOR
Intervention: Standard schedule of court hearings
Number of subjects: 0
Study 15139484 — intervention group
Group type: EXPERIMENTAL
Intervention: Dilatation with a 54‐F Savary dilator
Number of subjects: 11
Study 15139484 — intervention group
Group type: EXPERIMENTAL
Intervention: Four quadrant incisions with a needle knife
Number of subjects: 11
Study 11323010 — intervention group
Group type: EXPERIMENTAL
Intervention: Impedance plethysmography (IPG)
Number of subjects: 324
Study 11323010 — intervention group
Group type: COMPARATOR
Intervention: Contrast venography (CV)
Number of subjects: 324
Study 9348677 — intervention group
Group type: EXPERIMENTAL
Intervention: Foreign speech
Number of subjects: 72
Study 9348677 — intervention group
Group type: EXPERIMENTAL
Intervention: Pink noise
Number of subjects: 72
Study 9348677 — intervention group
Group type: COMPARATOR
Intervention: Silence
Number of subjects: 72
Study 9348677 — intervention group
Group type: EXPERIMENTAL
Intervention: Retest after four weeks
Number of subjects: 72
Study 9348677 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal consistency measure
Number of subjects: 72
Study 9348677 — intervention group
Group type: EXPERIMENTAL
Intervention: Original error rates
Number of subjects: 72
Study 9348677 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-report measures of noise susceptibility
Number of subjects: 72
Study 2890900 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic sclerosis (ES) plus cimetidine
Number of subjects: 113
Study 2890900 — intervention group
Group type: COMPARATOR
Intervention: Cimetidine alone (Control)
Number of subjects: 113
Study 29930373 — intervention group
Group type: EXPERIMENTAL
Intervention: Insignia customised orthodontic system
Number of subjects: 174
Study 29930373 — intervention group
Group type: COMPARATOR
Intervention: Damon Q noncustomised orthodontic system
Number of subjects: 174
Study 27707442 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal Dilator Strip (NDS)
Number of subjects: 26
Study 27707442 — intervention group
Group type: COMPARATOR
Intervention: Continuous Positive Airway Pressure (CPAP)
Number of subjects: 26
Study 26051110 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly 35 mg risedronate
Number of subjects: 290
Study 26051110 — intervention group
Group type: COMPARATOR
Intervention: Daily 5 mg risedronate
Number of subjects: 290
Study 23677653 — intervention group
Group type: COMPARATOR
Intervention: Daily injections of filgrastim (100 μg/m(2))
Number of subjects: 61
Study 23677653 — intervention group
Group type: EXPERIMENTAL
Intervention: DA‐3031 3.6 mg
Number of subjects: 61
Study 23677653 — intervention group
Group type: EXPERIMENTAL
Intervention: DA‐3031 6 mg
Number of subjects: 61
Study 21596879 — intervention group
Group type: EXPERIMENTAL
Intervention: Fospropofol IV infusion with a bolus and increased infusion rate for agitation events (infusion/bolus)
Number of subjects: 60
Study 21596879 — intervention group
Group type: EXPERIMENTAL
Intervention: Fospropofol IV infusion with an increased infusion rate for agitation events (infusion only)
Number of subjects: 60
Study 21596879 — intervention group
Group type: COMPARATOR
Intervention: Propofol IV infusion with an increased infusion rate for agitation events
Number of subjects: 60
Study 19565403 — intervention group
Group type: EXPERIMENTAL
Intervention: Tonsillectomy (n=33)
Number of subjects: 67
Study 19565403 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial tonsillectomy (tonsillotomy) (n=34)
Number of subjects: 67
Study 19565403 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=76)
Number of subjects: 67
Study 17040924 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural intervention involving training of network leaders to counsel their social network members on risk prevention
Number of subjects: 286
Study 17040924 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 286
Study 12780882 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentamicin fleece plus primary closure (Genta Group)
Number of subjects: 103
Study 12780882 — intervention group
Group type: COMPARATOR
Intervention: Open treatment alone (Open Group)
Number of subjects: 103
Study 10853884 — intervention group
Group type: EXPERIMENTAL
Intervention: propofol 6% SAZN
Number of subjects: 24
Study 10853884 — intervention group
Group type: COMPARATOR
Intervention: propofol 1% SAZN
Number of subjects: 24
Study 10853884 — intervention group
Group type: COMPARATOR
Intervention: Diprivan-10
Number of subjects: 24
Study 8883120 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily oral alendronate
Number of subjects: 1609
Study 8883120 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiographic absorptiometry (RA) of the phalanges
Number of subjects: 1609
Study 8883120 — intervention group
Group type: EXPERIMENTAL
Intervention: Single‐energy X‐ray absorptiometry (SXA)
Number of subjects: 1609
Study 8883120 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual‐energy X‐ray absorptiometry (DXA)
Number of subjects: 1609
Study 8883120 — intervention group
Group type: EXPERIMENTAL
Intervention: Duplicate measurements
Number of subjects: 1609
Study 8883120 — intervention group
Group type: COMPARATOR
Intervention: Healthy premenopausal women (reference group)
Number of subjects: 1609
Study 1595914 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraarticular bupivacaine (0.25%, with or without 1:200,000 epinephrine)
Number of subjects: 139
Study 1595914 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraarticular morphine (0.03%, with or without 1:200,000 epinephrine)
Number of subjects: 139
Study 1595914 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 139
Study 6392164 — intervention group
Group type: EXPERIMENTAL
Intervention: Hexabrix
Number of subjects: 50
Study 6392164 — intervention group
Group type: COMPARATOR
Intervention: Renografin‐76
Number of subjects: 50
Study 29984565 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise and high-intensity respiratory muscle training (24 supervised sessions, 3 per week, 8 weeks)
Number of subjects: 37
Study 29984565 — intervention group
Group type: COMPARATOR
Intervention: Usual post-operative care
Number of subjects: 37
Study 27209505 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin (100 mg/m2) or Cisplatin (75 mg/m2) plus Tirapazamine with concurrent radiation therapy (70 Gy over 7 weeks)
Number of subjects: 200
Study 26871969 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous exercise training (n=18)
Number of subjects: 35
Study 26871969 — intervention group
Group type: EXPERIMENTAL
Intervention: Interval exercise training (n=17)
Number of subjects: 35
Study 24638013 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin plus pemetrexed (CP)
Number of subjects: 150
Study 24638013 — intervention group
Group type: EXPERIMENTAL
Intervention: Erlotinib 150 mg for 1 year
Number of subjects: 150
Study 24638013 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up
Number of subjects: 150
Study 24638013 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall trial success rate
Number of subjects: 150
Study 22610128 — intervention group
Group type: EXPERIMENTAL
Intervention: Hippotherapy simulator ON
Number of subjects: 38
Study 22610128 — intervention group
Group type: EXPERIMENTAL
Intervention: Hippotherapy simulator ON (severely disabled group)
Number of subjects: 38
Study 22610128 — intervention group
Group type: COMPARATOR
Intervention: Hippotherapy simulator OFF
Number of subjects: 38
Study 19652234 — intervention group
Group type: EXPERIMENTAL
Intervention: Computed tomography-guided aspiration
Number of subjects: 841
Study 19652234 — intervention group
Group type: COMPARATOR
Intervention: Key-hole approach
Number of subjects: 841
Study 19652234 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 841
Study 17720111 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulating catheter (SC)
Number of subjects: 70
Study 17720111 — intervention group
Group type: COMPARATOR
Intervention: Nonstimulating catheter (NSC)
Number of subjects: 70
Study 15222827 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct observation methods and systematic time sampling
Number of subjects: 177
Study 11277444 — intervention group
Group type: EXPERIMENTAL
Intervention: Left visual-field (right-hemisphere function)
Number of subjects: 80
Study 11277444 — intervention group
Group type: COMPARATOR
Intervention: Hemispheric advantage in perception of happy expression
Number of subjects: 80
Study 9700280 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth Monitoring Teaching Aid (GMTA) used for 2-4 hours
Number of subjects: 30
Study 9700280 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study 7912725 — intervention group
Group type: EXPERIMENTAL
Intervention: Taxotere (docetaxel) at 110 mg/m2 per course
Number of subjects: 32
Study 7912725 — intervention group
Group type: EXPERIMENTAL
Intervention: Taxotere (docetaxel)
Number of subjects: 32
Study 2741669 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 25
Study 2741669 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 25
Study 2741669 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 2741669 — intervention group
Group type: COMPARATOR
Intervention: Urapidil
Number of subjects: 25
Study 2741669 — intervention group
Group type: COMPARATOR
Intervention: Trazodone
Number of subjects: 25
Study 51514 — intervention group
Group type: EXPERIMENTAL
Intervention: Cromolyn sodium
Number of subjects: 36
Study 51514 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 31222342 — intervention group
Group type: COMPARATOR
Intervention: Methionine supplementation (0, 0.075, 0.15, 0.225, and 0.30%)
Number of subjects: 300
Study 31222342 — intervention group
Group type: COMPARATOR
Intervention: Dietary energy level of 12.95 MJ/kg
Number of subjects: 300
Study 31222342 — intervention group
Group type: EXPERIMENTAL
Intervention: Methionine supplementation
Number of subjects: 300
Study 31222342 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary energy level
Number of subjects: 300
Study 31222342 — intervention group
Group type: EXPERIMENTAL
Intervention: Interaction of dietary energy and supplemental Met level
Number of subjects: 300
Study 31222342 — intervention group
Group type: EXPERIMENTAL
Intervention: Methionine requirements at 10.82 MJ/kg ME
Number of subjects: 300
Study 31222342 — intervention group
Group type: EXPERIMENTAL
Intervention: Methionine requirements at 12.95 MJ/kg ME
Number of subjects: 300
Study 31222342 — intervention group
Group type: EXPERIMENTAL
Intervention: Methionine requirements expressed as g/MJ ME of diet
Number of subjects: 300
Study 31222342 — intervention group
Group type: EXPERIMENTAL
Intervention: Methionine requirement differences
Number of subjects: 300
Study 28416500 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced online canteen ordering system with evidence‐based strategies targeting availability, menu labelling, placement and prompting.
Number of subjects: 1040
Study 28416500 — intervention group
Group type: COMPARATOR
Intervention: Standard online ordering only (control group).
Number of subjects: 1040
Study 25893157 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Navigation (PN) program
Number of subjects: 872
Study 22692114 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 ml of water (W)
Number of subjects: 10
Study 22692114 — intervention group
Group type: EXPERIMENTAL
Intervention: Salt-water (SW, 40 mM Na)
Number of subjects: 10
Study 22692114 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate-electrolyte solution with 3% or light carbohydrate (CES-L, 20 mM Na)
Number of subjects: 10
Study 22692114 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate-electrolyte solution with 6% carbohydrate (CES, 20 mM Na)
Number of subjects: 10
Study 21757458 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinapril
Number of subjects: 2553
Study 21757458 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2553
Study 20071896 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy and rhythmic exercise (twice a week for 8 weeks)
Number of subjects: 35
Study 16492702 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronized fenofibrate (267 mg/d)
Number of subjects: 91
Study 16492702 — intervention group
Group type: COMPARATOR
Intervention: AHA step 1 diet
Number of subjects: 91
Study 16492702 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study 12837876 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol/Fentanyl (P/F)
Number of subjects: 113
Study 12837876 — intervention group
Group type: COMPARATOR
Intervention: Ketamine/Midazolam (K/M)
Number of subjects: 113
Study 11146956 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous blood gas monitoring (CDI 500)
Number of subjects: 59
Study 11146956 — intervention group
Group type: COMPARATOR
Intervention: Intermittent blood gas monitoring
Number of subjects: 59
Study 9022524 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspartame treatment group
Number of subjects: 163
Study 9022524 — intervention group
Group type: COMPARATOR
Intervention: No aspartame treatment group
Number of subjects: 163
Study 11767314 — intervention group
Group type: EXPERIMENTAL
Intervention: Temazepam 20 mg
Number of subjects: 67
Study 11767314 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 15 mg
Number of subjects: 67
Study 11767314 — intervention group
Group type: COMPARATOR
Intervention: No medication
Number of subjects: 67
Study 11767314 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study 3510822 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxitropium bromide 100 micrograms
Number of subjects: 24
Study 3510822 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxitropium bromide 200 micrograms
Number of subjects: 24
Study 3510822 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxitropium bromide 300 micrograms
Number of subjects: 24
Study 3510822 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxitropium bromide (200 micrograms) and fenoterol (400 micrograms) combination
Number of subjects: 24
Study 3510822 — intervention group
Group type: COMPARATOR
Intervention: Fenoterol 400 micrograms
Number of subjects: 24
Study 30710391 — intervention group
Group type: EXPERIMENTAL
Intervention: CEP-26401 (5 μg)
Number of subjects: 40
Study 30710391 — intervention group
Group type: EXPERIMENTAL
Intervention: CEP-26401 (25 μg)
Number of subjects: 40
Study 30710391 — intervention group
Group type: EXPERIMENTAL
Intervention: CEP-26401 (125 μg)
Number of subjects: 40
Study 30710391 — intervention group
Group type: COMPARATOR
Intervention: Modafinil (200 mg)
Number of subjects: 40
Study 30710391 — intervention group
Group type: COMPARATOR
Intervention: Donepezil (10 mg)
Number of subjects: 40
Study 30032977 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma
Number of subjects: 125
Study 30032977 — intervention group
Group type: COMPARATOR
Intervention: Normal Saline (Control)
Number of subjects: 125
Study 26865535 — intervention group
Group type: EXPERIMENTAL
Intervention: Alogliptin 12.5 mg
Number of subjects: 2639
Study 26865535 — intervention group
Group type: EXPERIMENTAL
Intervention: Alogliptin 25 mg
Number of subjects: 2639
Study 26865535 — intervention group
Group type: COMPARATOR
Intervention: Glipizide (≤20 mg daily)
Number of subjects: 2639
Study 23586451 — intervention group
Group type: EXPERIMENTAL
Intervention: Reinforcement interventions with two or more job-related activities
Number of subjects: 185
Study 23586451 — intervention group
Group type: COMPARATOR
Intervention: Reinforcement interventions with one or no job-related activities
Number of subjects: 185
Study 22292000 — intervention group
Group type: EXPERIMENTAL
Intervention: High empathy condition (cognitive empathy) while listening to sad operatic content
Number of subjects: 56
Study 22292000 — intervention group
Group type: EXPERIMENTAL
Intervention: High empathy condition (cognitive empathy) while listening to happy operatic content
Number of subjects: 56
Study 22292000 — intervention group
Group type: COMPARATOR
Intervention: Low empathy condition while listening to sad operatic content
Number of subjects: 56
Study 22292000 — intervention group
Group type: COMPARATOR
Intervention: Low empathy condition while listening to happy operatic content
Number of subjects: 56
Study 19091308 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive CBM
Number of subjects: 48
Study 19091308 — intervention group
Group type: COMPARATOR
Intervention: Negative CBM
Number of subjects: 48
Study 17931408 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocaine (0.2 mg/kg) administered under 100% probability ('unblinded')
Number of subjects: 45
Study 17931408 — intervention group
Group type: COMPARATOR
Intervention: Cocaine (0.2 mg/kg) administered under 33% probability ('blinded')
Number of subjects: 45
Study 14598981 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 10839761 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin treatment for 3 months
Number of subjects: 302
Study 10839761 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 302
Study 9286227 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol-containing solution (4% w/v, 4.06 kcal/min, 1190 mosmol/kg)
Number of subjects: 8
Study 9286227 — intervention group
Group type: COMPARATOR
Intervention: Ethanol-free solution (2.64 kcal/min, 160 mosmol/kg)
Number of subjects: 8
Study 9286227 — intervention group
Group type: COMPARATOR
Intervention: Ethanol-free hyperosmolar solution (4.06 kcal/min, 1160 mosmol/kg)
Number of subjects: 8
Study 8450782 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexfenfluramine
Number of subjects: 40
Study 8450782 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 3766636 — intervention group
Group type: EXPERIMENTAL
Intervention: Progesterone
Number of subjects: 82
Study 3766636 — intervention group
Group type: COMPARATOR
Intervention: Clomiphene citrate
Number of subjects: 82
Study 29747957 — intervention group
Group type: EXPERIMENTAL
Intervention: Print-based intervention
Number of subjects: 52
Study 29747957 — intervention group
Group type: EXPERIMENTAL
Intervention: Move-It intervention
Number of subjects: 52
Study 29747957 — intervention group
Group type: EXPERIMENTAL
Intervention: Move-It plus support intervention
Number of subjects: 52